Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 5, 2006, Pages 335-340

  Alp, Emine ^a   Esel, Duygu ^a   Yildiz, Orhan ^a   Voss, Andreas ^b,c   Melchers, Willem ^b   Doganay, Mehmet ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; CEFEPIME; CEFTAZIDIME; CHLORAMPHENICOL; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; SULTAMICILLIN; TETRACYCLINE; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIUM COLONY; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD CULTURE; CONTROLLED STUDY; DATA COLLECTION METHOD; DIFFUSION; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; GENETIC ANALYSIS; GENOTYPE; HEALTH PROGRAM; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; MALE; MORTALITY; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; TREATMENT OUTCOME; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; APACHE; BACTEREMIA; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; TURKEY;

EID: 33744827155     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540500488907     Document Type: Article

References (34)

1. Rupp, ME.(2004) Nosocomial bloodstream infections. In Hospital Epidemiology and Infection Control 3rd edn. (pp. 253-65). Philadelphia: Lippincott Williams & Wilkins.
2. Weinstein, MP and Towns, ML and Quartey, SM and Mirrett, S and Reimer, LG and Parmigiani, G and et al (1997) The clinical significance of positive blood cultures in the 1990s: A prospective coprehensive evaluation of the microbiology, epidemiology, and outcome of bacteraemia and fungemia in adults Clin Infect Dis, 24, pp. 584-602.
3. Correa, L and Pittet, D. (2000) Problems and solutions in hospital-acquired bacteraemia J Hosp Infect, 46, pp. 89-95.
4. Smolyakov, R and Borer, A and Riesenberg, K and Schlaeffer, F and Alkan, M and Porath, A and et al (2003) Nosocomial multidrug-resistant Acinetobacter baumannii bloodstream infection: Risk factors and outcome with ampicillin-sulbactam treatment J Hosp Infect, 54, pp. 32-8.
5. Blot, S and Vandewoude, K and Colardyn, F. (2003) Nosocomial bacteraemia involving Acinetobacter baumannii in critically ill patients: A matched cohort study Intensive Care Med, 29, pp. 471-5.
6. Gomez, J and Simarro, E and Banos, V and Requena, L and Ruiz, J and Garcia, F. and et al (1999) Six-year prospective study of risk and prognostic factors in patients with nosocomial sepsis caused by Acinetobacter baumannii Eur J Clin Microbiol Infect Dis, 18, pp. 358-61.
7. Esel, D and Doganay, M and Alp, E and Sumerkan, B. (2003) Prospective evaluation of blood cultures in a Turkish university hospital: epidemiology, microbiology and patient outcome Clin Microbiol Infect, 9, pp. 1038-44.
8. Huang, YC and Su, LH and Wu, TL and Leu, HS and Hsieh, WS and Chang, TM and et al (2002) Outbreak of Acinetobacter baumannii bacteraemia in a neonatal intensive care unit: Clinical implications and genotyping analysis Pediatr Infect Dis J, 21, pp. 1105-9.
9. Bayat, A and Shhaban, H and Dodgson, A and Dunn, KW. (2003) Implications for burn unit design following outbreak of multi-resistant Acinetobacter infection in ICU and burns unit Burns, 29, pp. 303-6.
10. Landman, D and Quale, JM and Mayorga, D and Adedeji, A and Vangala, K and Ravishankar, J and et al (2002) Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY Arch Intern Med, 162, pp. 1515-20.
11. McCabe, WR and Jackson, GG. (1962) Gram-negative bacteraemia. I. Aetiology and ecology Arch Intern Med, 110, pp. 847.
12. Charlson, ME and Pompei, P and Ales, KL and MacKenzei, CR. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chron Dis, 40, pp. 373.
13. Wisplinghoff, H and Edmond, MB and Pfaller, MA and Jones, RN and Wenzel, RP and Seifert, H. (2000) Nosocomial bloodstream infections caused by Acinetobacter species in United States hospitals: Clinical features, molecular epidemiology, and antimicrobial susceptibility Clin Infect Dis, 31, pp. 690-7.
14. BouzaE, MolinaJP, MunozP, Cooperative Group of the European Study Group on Nosocomial Infections (ESGNI). Report of ESGNI-001 and ESGNI-002 studies. Bloodstream infections in Europe. Clin Microbiol Infect 1999;5(Suppl. 2):1-12.
15. American College of Chest Physicians/Society of Critical Care Medicine. (1992) Consensus conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis Crit Care Med, 20, pp. 864.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 11th informational supplement. M100-S11. WaynePA: NCCLS, 2001.
17. Debast, SB and Meis, JF and Melchers, WJ and Hoogkamp-Korstanje, JA and Voss, A. (1996) Use of interrepeat PCR fingerprinting to investigate an Acinetobacter baumannii outbreak in an intensive care unit Scand J Infect Dis, 28, pp. 577-81.
18. Akopyanz, N and Bukanov, NO and Westblom, TU and Kresovich, S and Berg, DE. (1992) DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting Nucleic Acids Res, 20, pp. 5137-42.
19. Rello, J and Diaz, E. (2003) Acinetobacter baumannii: A threat for the ICU? Intensive Care Med, 29, pp. 350-1.
20. Ayan, M and Durmaz, R and Aktas, E and Durmaz, B. (2003) Bacteriological, clinical and epidemiological characteristics of hospital-acquired Acinetobacter baumannii infection in ateaching hospital J Hosp Infect, 54, pp. 39-45.
21. Flaherty, JP and Stosor, V.(2004) Non-fermentative Gram-negative bacilli. In Hospital Epidemiology and Infection Control3rd edn. (pp. 575-602). Philadelphia: Lippincott Williams & Wilkins.
22. Rello, J. (1999) Acinetobacter baumannii infections in the ICU Chest, 115, pp. 1226-9.
23. Cisneros, JM and Rodriguez-Bano, J. (2002) Nosocomial bacteraemia due to Acinetobacter baumannii: Epidemiology, clinical features and treatment Clin Microb Infect, 8, pp. 687-93.
24. Denton, M and Wilcox, MH and Parnell, P and et al (2004) Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit J Hosp Infect, 56, pp. 106-10.
25. Herruzo, R and Cruz, J de la and Fernandez-Acenero, MJ and Garcia-Caballero, J. (2004) Two consecutive outbreaks of Acinetobacter baumannii 1a in a burn intensive care unit for adults Burns, 30, pp. 419-23.
26. Husni, RN and Goldstein, LS and Arroliga, AC and et al (1999) Risk factors for an outbreak of multidrug-resistant Acinetobacter nosocomial pneumonia among intubated patients Chest, 115, pp. 1378-82.
27. Kaul, R and Burt, JA and Cork, L and Dedier, H and Garcia, M and Kennedy, C and et al (1996) Investigation of a multi-y multiple critical care unit outbreak due to relatively drug-sensitive Acinetobacter baumannii: Risk factors and attributable mortality J Infect Dis, 174, pp. 1279-87.
28. Wang, SH and Sheng, WH and Chang, YY and Wang, LH and Lin, HC and Chen, ML and et al (2003) Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit J Hosp Infect, 53, pp. 97-102.
29. Wagenvoort, JHT and De Brauwer, EIGB and Toenbreker, HMJ and van der Linden, CJ. (2002) Epidemic Acinetobacter baumannii strain with MRSA-like behaviour carried by health care staff Eur J Clin Microbiol Infect Dis, 21, pp. 326-7.
30. Fagon, JY and Chastre, J and Domart, Y and et al. (1989) Nosocomial pneumonia in patients receiving continous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques Am Rev Respir Dis, 139, pp. 877-84.
31. Siau, H and Yuen, KY and Ho, PL and Wong, SSY and Woo, PCY. (1999) Acinetobacter bacteraemia in Hong Kong: Prospective study and review Clin Infect Dis, 28, pp. 26-30.
32. Rello, J and Quintana, E and Ausina, V and Castella, J and Luquin, M and Net, A and et al (1991) Incidence, aetiology and outcome of nosocomial pneumonia in mechanically ventilated patients Chest, 100, pp. 439-44.
33. Torres, A and Aznar, R and Gatell, JM and Jimenez, P and Gonalez, J and Ferrer, A and et al (1990) Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients Am Rev Respir Dis, 142, pp. 523-8.
34. Wood, GC and Hanes, SD and Croce, MA and Fabian, TC and Boucher, BA. (2002) Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of Acinetobacter ventilator-associated pneumonia Clin Infect Dis, 34, pp. 1425-30.